Literature DB >> 445466

Neutral fucolipids and fucogangliosides of rat hepatoma HTC and H35 cells, rat liver, and hepatocytes.

H Baumann, E Nudelman, K Watanabe, S Hakomori.   

Abstract

Neutral fucolipids and fucogangliosides of normal rat liver, normal rat hepatocytes, and rat hepatoma H35 and HTC cells have been compared. H35 cells were characterized by accumulation of a relatively large quantity of a few neutral fucolipids and a major fucoganglioside. HTC cells were characterized by accumulation of several neutral fucolipids and by the absence of fucogangliosides. Those fucolipids which accumulated in hepatoma cells were absent in normal rat liver and normal hepatocytes. Normal hepatocytes and normal rat liver contained a low quantity of fucolipids which migrated differently on thin-layer chromatography from those which accumulated in hepatoma cells. In addition to these qualitative differences, the quantity of total fucose in purified glycolipid fraction was much higher in H35 and significantly higher in HTC cells than that in rat liver. A fucoganglioside which accumulated in H35 cells was tentatively characterized as a fucosylated GM1 ganglioside with the following structure: (formula: see text). The results indicate that anomalous fucosylation on glycolipid may take place in hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445466

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Capturing and identification of differentially expressed fucome by a gel free and label free approach.

Authors:  Chanida Puangpila; Ziad El Rassi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-03-14       Impact factor: 3.205

2.  Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study.

Authors:  Kiminori Watanabe; Masayuki Ohta; Kazuhiro Yada; Yoko Komori; Yukio Iwashita; Kenji Kashima; Masafumi Inomata
Journal:  Surg Today       Date:  2016-01-11       Impact factor: 2.549

3.  Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.

Authors:  Miguel C Lucena; Patricia Carvalho-Cruz; Joana L Donadio; Isadora A Oliveira; Rafaela M de Queiroz; Monica M Marinho-Carvalho; Mauro Sola-Penna; Iron F de Paula; Katia C Gondim; Mark E McComb; Catherine E Costello; Stephen A Whelan; Adriane R Todeschini; Wagner B Dias
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

4.  Thin-layer and liquid column chromatographic analyses of the lipids of adult Onchocerca gibsoni.

Authors:  M D Maloney; L H Semprevivo
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 5.  Circulating cancer stem cells: the importance to select.

Authors:  Ming-Hsin Yang; Ahmet Imrali; Christopher Heeschen
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

Review 6.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

7.  Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway.

Authors:  A Vasconcelos-Dos-Santos; H F B R Loponte; N R Mantuano; I A Oliveira; I F de Paula; L K Teixeira; J C M de-Freitas-Junior; K C Gondim; N Heise; R Mohana-Borges; J A Morgado-Díaz; W B Dias; A R Todeschini
Journal:  Oncogenesis       Date:  2017-03-20       Impact factor: 7.485

8.  Preferential degradation of the terminal carbohydrate moiety of membrane glycoproteins in rat hepatoma cells and after transfer to the membranes of mouse fibroblasts.

Authors:  H Baumann; E Hou; G P Jahreis
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

9.  Dexamethasone increases the synthesis and secretion of a partially active fibronectin in rat hepatoma cells.

Authors:  H Baumann; D Eldredge
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

10.  Fucosylation is a promising target for cancer diagnosis and therapy.

Authors:  Eiji Miyoshi; Kenta Moriwaki; Naoko Terao; Cheng-Cheng Tan; Mika Terao; Tsutomu Nakagawa; Hitoshi Matsumoto; Shinichiro Shinzaki; Yoshihiro Kamada
Journal:  Biomolecules       Date:  2012-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.